INTRODUCTION
============

Epithelial plasticity permits simple or stratified epithelial tissues to actively modulate their cohesiveness and differentiated phenotypes in response to extracellular stimuli. An exemplary form of epithelial plasticity is the epithelial--mesenchymal transition (EMT), a phenotypic switch in which epithelial cells detach from their neighbors, acquire mesenchymal attributes, and become motile and invasive. This switch in cell fate is driven by characteristic changes in gene expression, including decreases in E-cadherin and increases in Snail-family transcription factors. During embryonic development, EMT endows the epithelium with sufficient plasticity to form the mesoderm, the neural crest, and the heart valves ([@B57]). EMT likewise promotes epithelial plasticity during postnatal morphogenesis, particularly in mammary branching ([@B41]). Recent evidence suggests that EMT may also be activated in the adult under pathological conditions, including fibrosis and cancer ([@B2]; [@B34]). Tumors that express mesenchymal markers have a greater tendency to be invasive and metastasize than those that do not and are associated with a poor prognosis ([@B21]; [@B36]).

These normal and pathological transitions in epithelial cell fate are highly regulated by soluble signals in the microenvironment. Matrix metalloproteinases (MMPs) are extracellular enzymes important for a wide variety of developmental and pathological processes associated with extensive tissue remodeling ([@B35]). MMPs play a critical role in the development of many organs, including the mammary gland, where these enzymes control morphogenesis during puberty and epithelial remodeling during postlactational involution ([@B73]; [@B78]; [@B77]). MMP3 (stromelysin-1) and MMP7 (matrilysin-1) have been shown to induce EMT-associated fibrosis and carcinogenesis in adult transgenic mice ([@B46], [@B47]; [@B66]; [@B72]; [@B58]), and are associated with a number of human malignancies, including breast cancer ([@B26]; [@B54]; [@B24]). In mammary epithelial cells cultured on noncompliant substrata such as glass or polystyrene, treatment with MMP3 induces the expression of Rac1b ([@B64]), which is a splice variant of the small GTPase Rac1 that contains an additional 19 amino acids adjacent to the switch II domain (a region important for interaction with effectors), resulting in impaired intrinsic GTPase activity ([@B71]). Rac1b is expressed in a variety of human cancers, including carcinomas of the breast and colon, where its expression sustains tumor cell survival ([@B50], [@B51]; [@B52]) and is highly correlated with malignant progression ([@B32]; [@B68]; [@B71]). Sustained expression of Rac1b elevates levels of cellular reactive oxygen species (ROS) and promotes expression of the EMT-associated transcription factor Snail ([@B64]). In vivo, these alterations cause excessive deposition of extracellular matrix (ECM), disruptions in tissue structure, and fibrotic stiffening ([@B72]). Although misexpression in the adult can have deleterious consequences, MMPs are expressed at high levels during development without causing pathological EMT or fibrosis, suggesting the existence of protective mechanisms in the micro­environment of normal tissues.

Mechanical signals from the microenvironment are important contributors to both normal and pathological developmental processes. The mechanical compliance, or rigidity, of the ECM substratum profoundly affects cell morphology, with stiffer substrata promoting integrin clustering, focal adhesion formation, cell spreading, and intracellular tension ([@B75]; [@B18]; [@B79]; [@B25]). Substratum rigidity also regulates cell behaviors, including motility, proliferation, and differentiation ([@B61]; [@B45]; [@B62]; [@B19]; [@B39]; [@B49]). In the mammary gland, stiff matrices with compliances characteristic of the average mammary tumor have been shown to disrupt mammary ductal architecture ([@B63]) and to promote neoplastic progression and a malignant phenotype ([@B60]; [@B63]; [@B43]). Conversely, soft matrices with compliances comparable to that of the normal mammary gland promote normal mammary functional differentiation ([@B3]). The molecular basis for these stiffness-mediated effects remains ill defined but is usually attributed to possible alterations in the transmission of force from focal adhesions through the actin cytoskeleton to the nucleus ([@B69]; [@B20]).

Here we examine the role of the mechanical properties of the microenvironment in the regulation of epithelial plasticity via EMT. We use synthetic polyacrylamide substrata to mimic the mechanical properties of the normal murine mammary gland, which is refractory to EMT induction via MMP3, and those of the average mammary tumor, in which these signals promote EMT. Using this system, we show that stiffness-dependent control of epithelial plasticity is mediated by membrane targeting of Rac1b and consequent assembly and activation of NADPH oxidase to catalyze the production of ROS. Consistent with these observations, immunohistochemical analysis of Rac1b in human breast tissue biopsies reveals increased expression and altered cellular localization in desmoplastic regions of human breast tumors as compared with normal breast tissue. We further find that exogenously controlling the membrane localization of Rac1b bypasses signals from the mechanical microenvironment for induction of EMT. This study demonstrates that matrix compliance can drive EMT by controlling the localization and activity of molecular switches and unveils a novel mechanotransduction pathway independent of the direct transmission of force through the cytoskeleton.

RESULTS
=======

The mechanical microenvironment controls induction of EMT by MMP3
-----------------------------------------------------------------

Treatment of mammary epithelial cells with MMP3 results in cell scattering ([Figure 1A](#F1){ref-type="fig"}) and gene expression changes consistent with an EMT program, including down-regulation of epithelial markers such as keratins and E-cadherin and up-regulation of the mesenchymal markers vimentin and α-smooth muscle actin (αSMA) ([Figure 1, B and C](#F1){ref-type="fig"}). To investigate the role of substratum compliance in MMP3-induced EMT, we cultured cells on ECM-coated polyacrylamide substrata with a range of compliances (reported as Young\'s modulus, *E*) spanning those of the normal mammary gland and the average mammary tumor ([Figure 1D](#F1){ref-type="fig"} and Supplemental Figure S1). On stiff substrata, exposure to MMP3 resulted in dissolution of intercellular adhesions and cell scattering ([Figure 1E](#F1){ref-type="fig"}), as well as down-regulation of epithelial keratins and E-cadherin and up-regulation of Snail, vimentin, and αSMA at both the transcript and protein levels ([Figure 1, F--H](#F1){ref-type="fig"}, and Supplemental Figure S2). Conversely, cells cultured on soft substrata were unresponsive to treatment with MMP3 and failed to scatter or express the EMT proteome ([Figure 1, E--H](#F1){ref-type="fig"}, and Supplemental Figure S2). These data show that a microenvironment with physiologically normal compliance is protective of the epithelial cell phenotype and prevents EMT in response to MMP3.

![Soft, compliant substratum protects against MMP3-induced EMT. (A) Phase contrast images of control and MMP3-treated mammary epithelial cells on tissue culture--grade polystyrene. (B) Fold change in the transcript levels of EMT markers upon treatment with MMP3 in cells on polystyrene (*n* = 4). (C) Immunoblot analysis for EMT markers in control and MMP3-treated mammary epithelial cells on polystyrene. (D) Young\'s modulus (*E*) of polyacrylamide substrata as a function of bis-acrylamide concentration. Values reported for *E*~normal~ and *E*~tumor~ are from [@B60]). Error bars represent SD. (E) Phase contrast images of control and MMP3-treated mammary epithelial cells cultured on polyacrylamide substrata of soft (*E* ∼ 130 Pa) and stiff (*E* ∼ 4020 Pa) compliances. (F) Fluorescence images of control and MMP3-treated mammary epithelial cells cultured on polyacrylamide substrata of various compliances stained for keratins (red) and DNA (blue). (G) Relative keratin expression in MMP3-treated mammary epithelial cells on substrata of various compliances. (H) Fold change in the transcript levels of keratin-14 and vimentin upon treatment with MMP3 on substrata of various compliances (*n* = 4). Error bars represent SEM. \**p* \< 0.05, \*\**p* \< 0.01. Scale bars, 50 μm.](4097fig1){#F1}

Soft substrata block production of ROS downstream of MMP3 and Rac1b
-------------------------------------------------------------------

To determine how matrix compliance regulates MMP3-induced EMT, we evaluated the effect of substratum stiffness on downstream signaling. We found that treatment with MMP3 induced an increase in the levels of Rac1b that was independent of substratum rigidity ([Figure 2A](#F2){ref-type="fig"}); thus cells cultured on soft substrata still respond to MMP3 by increasing expression of Rac1b. Moreover, ectopic expression of Rac1b in the absence of MMP3 using a recombinant adenovirus (Ad-Rac1b; [Figure 2B](#F2){ref-type="fig"}) efficiently induced EMT in mammary epithelial cells cultured on polystyrene (Supplemental Figure S3) and on stiff polyacrylamide substrata ([Figure 2C](#F2){ref-type="fig"} and Supplemental Figure S4) but did not induce EMT in cells cultured on soft substrata ([Figure 2C](#F2){ref-type="fig"} and Supplemental Figure S4). We found that other downstream effects of MMP3-induced Rac1b expression, namely the increased cell spreading and production of ROS, were also only induced on stiff substrata, as cells cultured on soft substrata and treated with MMP3 showed significantly decreased cell spreading ([Figure 2D](#F2){ref-type="fig"}) and ROS induction ([Figure 2E](#F2){ref-type="fig"}) as compared with cells cultured on stiff substrata and treated with MMP3. Nonetheless, cells on soft substrata were still capable of undergoing EMT. Treatment with H~2~O~2~ to elevate the levels of ROS in the absence of MMP3 promoted EMT on all substrata, regardless of compliance ([Figure 2F](#F2){ref-type="fig"}). Similarly, ectopic expression of Snail using a recombinant adenovirus (Ad-Snail; [@B33]; [Figure 2G](#F2){ref-type="fig"}) also promoted EMT on all substrata, regardless of compliance ([Figure 2H](#F2){ref-type="fig"}). Soft substrata therefore block MMP3-induced EMT immediately downstream of Rac1b, suggesting that Rac1b is prevented from inducing ROS production in cells in soft, compliant microenvironments ([Figure 2I](#F2){ref-type="fig"}).

![Soft, compliant substratum blocks MMP3-mediated induction of cell spreading and generation of ROS. (A) Fold change in the transcript levels of Rac1b for MMP3-treated cells cultured on polyacrylamide substrata of varying compliances (*n* = 4). (B) Immunoblot analysis of Rac1b, Rac1, and β-actin in cells transduced with Ad-Rac1b or Ad-GFP control. (C) Fold change in the transcript levels of keratin-14 and vimentin for cells ectopically expressing Rac1b on substrata of various compliances (*n* = 4). (D) Projected cell area as a function of substratum compliance (*n* = 4; 50 cells/*n*). (E) Relative change in cellular ROS levels (assessed by DCFDA) in cells cultured on polyacrylamide substrata of various compliances and treated with MMP3 (*n* = 4; 50 cells/*n*). (F) Fold change in the transcript levels of keratin-14 and vimentin for cells treated with H~2~O~2~ (*n* = 4). (G) Immunoblot analysis of Snail, E-cadherin, and β-actin in cells transduced with Ad-Snail or Ad-GFP control. (H) Fold change in the transcript levels of keratin-14, vimentin, and E-cadherin for cells ectopically expressing Snail on substrata of various compliances (*n* = 3). (I) Scheme outlining EMT induction pathway for MMP3. Error bars represent SEM. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001.](4097fig2){#F2}

Transforming growth factor-β (TGFβ) is well recognized as a mediator of EMT in a variety of physiological contexts ([@B6]; [@B31]; [@B37]) and can be activated by treatment with H~2~O~2~ ([@B30]). To assess whether TGFβ activation plays a role in promoting MMP3-induced EMT in cells on stiff microenvironments, we monitored the amount of active and total TGFβ through the use of a luciferase reporter system ([@B1]). We found no difference in TGFβ activation or expression in the conditioned medium obtained from cells cultured on the different substrata (Supplemental Figure S5). Although this assay could not rule out differences in activated TGFβ that may have remained associated with the cell membrane or ECM, blocking TGFβ signaling by treating with a pharmacological inhibitor of the type I TGFβ receptor kinase did not affect the MMP3- or H~2~O~2~-induced EMT, as defined by down-regulation of keratin-14 and E-cadherin, or up-regulation of vimentin, αSMA, and Snail (Supplemental Figure S5).

Soft substrata inhibit ROS production by blocking assembly of Rac1b with NADPH oxidase
--------------------------------------------------------------------------------------

Treatment with ROS-quenching agents completely abrogates MMP3- and Rac1b-mediated induction of EMT in mammary epithelial cells ([@B64]; [@B55]). Rac-family members can regulate the production of ROS by associating with the multimolecular membrane-associated enzyme, NADPH oxidase ([@B29]). Upon translocation to the membrane, activated Rac binds to the Nox activator p67^phox^ to form an activated complex ([@B17]). Rac1b had not previously been shown to interact with NADPH oxidase, but we hypothesized that, as an activated GTPase, it may facilitate assembly of this enzyme. To characterize the role of matrix compliance in Rac1b-induced ROS production, we determined the expression levels of NADPH oxidase subunits in cells cultured on substrata of varying compliance. We found that components of NADPH oxidase, including the catalytic subunit gp91^phox^/Nox2, the Nox organizer p47^phox^, and the Nox activator p67^phox^, were expressed in mammary epithelial cells independent of substratum rigidity or Rac1b expression ([Figure 3A](#F3){ref-type="fig"}). Furthermore, Rac1b coimmunoprecipitated with components of the NADPH oxidase complex, including p67^phox^ and p47^phox^, when cells were cultured on stiff substrata ([Figure 3B](#F3){ref-type="fig"}). However, we found that formation of this complex was significantly diminished when cells were cultured on soft substrata ([Figure 3B](#F3){ref-type="fig"}). Similar stiffness-dependent assembly was observed in MCF10A human mammary epithelial cells (Supplemental Figure S6), suggesting that soft matrices inhibit the assembly of NADPH oxidase by blocking the interaction between Rac1b and p67^phox^. Consistent with these results, Rac1b-expressing cells cultured on soft substrata were prevented from producing ROS ([Figure 3C](#F3){ref-type="fig"}). Moreover, inhibiting NADPH oxidase using diphenylene iodonium (DPI) blocked induction of EMT by MMP3 ([Figure 3D](#F3){ref-type="fig"}) and Rac1b ([Figure 3E](#F3){ref-type="fig"}). These data show that soft, compliant substrata protect cells from MMP3-induced EMT by disrupting the interaction between Rac1b and NADPH oxidase and thereby inhibiting production of ROS.

![NADPH oxidase associates with Rac1b to mediate MMP3-induced EMT. (A) Immunoblot analysis of gp91^phox^, p67^phox^, p47^phox^, Rac1b, GFP, and β-actin for cells ectopically expressing Rac1b or control and cultured on substrata of various compliances. (B) SCp2 cells were transduced with GFP or YFP-Rac1b and grown on soft (130 Pa) or stiff (4020 Pa) substrata. Immunoprecipitation was performed using anti-GFP antibody. Whole-cell lysates and IP products were assayed by immunoblot analysis to detect p67^phox^, p47^phox^, Rac1b, and GFP. (C) Fold change in cellular ROS levels in cells transduced with Ad-Rac1b or Ad-GFP control and grown on soft or stiff substrata (*n* = 4; 60 cells/*n*). (D) Changes in EMT marker expression in cells treated with and without MMP3 and dimethyl sulfoxide (vehicle control) or the NADPH oxidase inhibitor DPI (*n* = 5). (E) Changes in EMT marker expression in cells transduced with Ad-Rac1b or Ad-GFP control and treated with vehicle or DPI (*n* = 4). Error bars represent SEM. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001.](4097fig3){#F3}

Soft substrata block localization of Rac1b to the plasma membrane
-----------------------------------------------------------------

Rac1b is a self-activating splice variant of Rac1 ([@B22]). That its association with NADPH oxidase and promotion of cellular ROS were inhibited by culture on soft substrata suggested that Rac1b signaling is regulated by mechanisms other than activation. Membrane localization of Rac1 is mediated by posttranslational prenylation ([@B16]) and is required for activation of its downstream effectors ([@B14], [@B13]), including NADPH oxidase--mediated generation of ROS ([@B4]; [@B27]). We therefore monitored the membrane localization of Rac1b in mammary epithelial cells by expressing ectopically a yellow fluorescent protein (YFP) fusion protein (YFP-Rac1b). In cells cultured on glass or stiff polyacrylamide substrata, YFP-Rac1b localized to the cell periphery and in membrane ruffles ([Figure 4A](#F4){ref-type="fig"}). However, in cells cultured on soft substrata, YFP-Rac1b was primarily internalized within a central region of the cytoplasm ([Figure 4A](#F4){ref-type="fig"}), similar to previously reported descriptions of the localization of Rac1 within cholesterol-enriched membrane microdomains in suspended cells ([@B11], [@B12]). These effects on the subcellular localization of Rac1b were confirmed via cellular fractionation followed by immunoblotting analysis (Supplemental Figure S6). These results indicate that soft, compliant substratum blocks the localization of Rac1b to the plasma membrane.

![Membrane localization of Rac1b is required for MMP3-induced EMT. (A) Fluorescence images of GFP, YFP-Rac1b, YFP-Rac1b-SAAX, and YFP-Rac1b-myr in SCp2 cells grown on substrata of various compliances. (B) SCp2 cells were transduced with GFP, YFP-Rac1b, YFP-Rac1b-SAAX, and YFP-Rac1b-myr and grown on soft (130 Pa) or stiff (4020 Pa) substrata. Immunoprecipitation was performed using anti-GFP antibody. Whole-cell lysates and immunoprecipitated products were assayed by immunoblot analysis to detect p67^phox^, Rac1b, and GFP. (C) Fold change in cellular ROS levels in cells transduced with GFP, Rac1b, Rac1b-myr, or Rac1b-SAAX (*n* = 4; 60 cells/*n*). (D, E) Fold change in the transcript levels of keratin-14 and vimentin for cells ectopically expressing YFP-Rac1b-SAAX (D) or YFP-Rac1b-myr (E; *n* = 4). (F) Disrupting isoprenoid biosynthesis using mevinolin reduces cholesterol levels (stained with filipin) and YFP-Rac1b localization to the membrane. (G) Marker transcript levels for cells treated with and without MMP3 and mevinolin; statistics indicate vehicle vs. mevinolin (*n* = 4). \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001. Scale bars, 10 μm.](4097fig4){#F4}

Isoprenylation of Rac1 occurs on a carboxy-terminal CAAX motif ([@B38]), which is located within the sixth coding exon and is conserved in the Rac1b splice variant; isoprenylation facilitates localization of Rac1 to the plasma membrane ([@B32]; [@B68]). To determine whether the membrane localization of Rac1b was required for its induction of EMT, we generated mutants that either blocked posttranslational isoprenylation by replacing the prenyl-attachment cysteine with a serine residue (Rac1b-SAAX) or had an additional membrane-targeting myristoylation signal (Rac1b-myr), thus either blocking or promoting association with the plasma membrane ([@B14]; [@B53]). Rac1b-SAAX was sequestered from the membrane on all culture surfaces and predominantly localized to the nucleus ([Figure 4A](#F4){ref-type="fig"}), consistent with previous reports showing that the carboxy-terminal polybasic region of Rac1 can act as a nuclear localization sequence ([@B40]). In contrast, Rac1b-myr was targeted to the plasma membrane on both stiff and soft substrata ([Figure 4A](#F4){ref-type="fig"}). These imaging results were confirmed by immunoblotting analysis of Rac1b in membrane fractions of the cell lysates (Supplemental Figure S6). Blocking membrane localization using Rac1b-SAAX inhibited the association between Rac1b and NADPH oxidase ([Figure 4B](#F4){ref-type="fig"}) and production of ROS ([Figure 4C](#F4){ref-type="fig"}). In contrast, promoting membrane localization using Rac1b-myr promoted the association between Rac1b and the NADPH oxidase complex even on soft substrata ([Figure 4B](#F4){ref-type="fig"}). To determine whether the membrane localization of Rac1b and subsequent production of ROS are required for Rac1b-induced EMT, we determined the expression levels of genes associated with EMT. Sequestering Rac1b away from the plasma membrane using Rac1b-SAAX blocked the induction of EMT in cells on all culture surfaces, including stiff substrata ([Figure 4D](#F4){ref-type="fig"} and Supplemental Figures S4 and S7). Conversely, targeting Rac1b to the membrane using Rac1b-myr induced EMT on both soft and stiff substrata ([Figure 4E](#F4){ref-type="fig"} and Supplemental Figures S4 and S7). Consistent with these results, disrupting isoprenoid biosynthesis using mevinolin (lovastatin) blocked YFP-Rac1b localization to the membrane ([Figure 4F](#F4){ref-type="fig"}) and abrogated the induction of EMT by MMP3 ([Figure 4G](#F4){ref-type="fig"}). These data suggest that localization of Rac1b to the plasma membrane is required for its downstream signaling and induction of EMT.

Rac1b localizes to the membrane in human breast tumors but not normal mammary gland
-----------------------------------------------------------------------------------

To determine how substratum stiffness--dependent regulation of Rac1b localization functions in vivo, we examined the distribution of the protein in situ in biopsies taken from nonmalignant human breast tissue and collagen-rich regions of human breast tumors, which are regions of enhanced stiffness ([@B63]; [@B43]; [@B48]). Immunohistochemical analysis revealed that the endogenously low levels of Rac1b were primarily cytoplasmic in normal mammary tissue ([Figure 5A](#F5){ref-type="fig"}). In marked contrast, Rac1b showed an apparent relocalization in the epithelial cells in collagen-rich regions of human breast tumors ([Figure 5B](#F5){ref-type="fig"}), consistent with our findings in cell culture models that stiff microenvironments promote Rac1b membrane localization and downstream signaling.

![Rac1b is localized to the membrane in human breast tumor epithelium but not nontumorigenic epithelium. Immunohistochemical analysis of collagen and Rac1b in (A) normal human mammary epithelium and (B) tumorigenic epithelium. Scale bars, 100 μm.](4097fig5){#F5}

Soft substrata control Rac1b localization through integrin clustering
---------------------------------------------------------------------

Rac1 is recruited to the plasma membrane and maintained in lipid rafts through signaling involving integrins and phosphorylated caveolin ([@B11], [@B12]). Integrins block the endocytosis of lipid rafts and maintain Rac1 at the surface by retaining phosphorylated caveolin within focal adhesions. That Rac1b was sequestered from the membrane when cells were cultured on soft substrata suggested that integrin-mediated adhesions would also be reduced under these conditions. We evaluated focal adhesions by staining for activated phosphorylated focal adhesion kinase (pFAK; [Figure 6A](#F6){ref-type="fig"}). We found that cells cultured on soft substrata had significantly fewer pFAK-containing focal adhesions than those cultured on stiff substrata ([Figure 6, B and C](#F6){ref-type="fig"}), consistent with previous reports ([@B60]; [@B76]). However, treatment with MMP3 increased the number of focal adhesions when cells were cultured on stiff, but not on soft, substrata ([Figure 6, A--C](#F6){ref-type="fig"}, and Supplemental Figure S6). Consistent with previous reports indicating a key role for β1-integrins in cellular response to substratum stiffness ([@B60]), we found that disrupting focal adhesions by knocking down β1-integrin ([Figure 7A](#F7){ref-type="fig"}) prevented MMP3-induced ROS ([Figure 7B](#F7){ref-type="fig"}) and EMT ([Figure 7C](#F7){ref-type="fig"}). Conversely, expressing an autoclustering β1-integrin mutant (β1^V737N^; [@B60]) promoted membrane localization of YFP-Rac1b ([Figure 7D](#F7){ref-type="fig"}) and allowed Rac1b to interact with NADPH oxidase ([Figure 7E](#F7){ref-type="fig"}). These changes resulted in significant production of ROS and promoted EMT on soft substrata ([Figure 7, F and G](#F7){ref-type="fig"}, and Supplemental Figure S7). These results indicate that integrin-mediated adhesion transduces mechanical signals to control membrane localization and functional activation of Rac1b, which in turn induces NADPH oxidase--mediated production of ROS and EMT.

![Substratum compliance alters focal adhesion formation. (A) Fluorescence images of cells cultured with or without MMP3 on substrata of various compliances and stained for pFAK Y397. (B) Quantification of the average number of FAs per cell in cells treated with or without MMP3 on substrata of various compliances. (C) Histogram of number of FAs in cells treated with or without MMP3 on substrata of various compliances. \**p* \< 0.05. Scale bars, 25 μm.](4097fig6){#F6}

![Clustering of β1-integrin is required for Rac1b localization to the membrane and MMP3-induced EMT. (A) Depletion of β1 integrin using short hairpin RNA (shRNA) targeting β1 integrin. (B) Fold change in cellular ROS levels in cells transfected with shRNA targeting β1-integrin (β1 KD) or scrambled shRNA (cntl; *n* = 4; 60 cells/*n*). (C) Fold change in the transcript levels of keratin-14 and vimentin for control cells or knockdown for β1-integrin (β1 KD; n = 3). (D) Fluorescence images of YFP-Rac1b in cells cultured on soft substrata and simultaneously expressing control β1-integrin or the autoclustering mutant β1^V737N^. Scale bars, 10 μm. (E) SCp2 cells were cotransfected with Rac1b together with β1^V737N^ and cultured on soft (130 Pa) or stiff (4020 Pa) substrata. Immunoprecipitation (IP) was performed using anti-Rac1b antibody. Whole-cell lysates and IP products were assayed by immunoblot analysis to detect p67^phox^ and Rac1b. (F) Fold change in cellular ROS levels in cells expressing Rac1b and β1^V737N^ and cultured on soft (130 Pa) or stiff (4020 Pa) substrata (*n* = 4; 60 cells/*n*). (G) Fold change in the transcript levels of keratin-14 and vimentin for cells simultaneously expressing Rac1b and β1^V737N^ and cultured on soft substrata (*n* = 4). Error bars represent SEM. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001.](4097fig7){#F7}

DISCUSSION
==========

Here we showed that soft microenvironments characteristic of the normal mammary gland protect against pathological insult from MMP3, which induces epithelial dedifferentiation and acquisition of fibrotic attributes in stiffer settings. These findings are congruent with the effects of mechanical stiffness on scattering of Madin--Darby canine kidney epithelial cells ([@B10]) and amplification of fibrosis in the lung ([@B44]). Although the mechanical compliance of the microenvironment is increasingly recognized as a regulator of cellular phenotype, the molecular basis for its effects on cells is largely undefined. Our data support a model in which substratum compliance regulates MMP3-induced EMT through integrin-mediated modulation of Rac1b localization, NADPH oxidase assembly, and downstream signaling ([Figure 8](#F8){ref-type="fig"}). In rigid microenvironments, Rac1b is recruited to the plasma membrane and interacts with components of the NADPH oxidase complex, which in turn induces ROS production, activation of Snail, and induction of EMT. In tissue-mimetic soft microenvironments, mammary epithelial cells form very few cell--ECM adhesions, Rac1b is not translocated to the membrane, and EMT is prevented. The mechanical properties of the tissue microenvironment thus modulate signaling events controlling epithelial plasticity.

![The role of matrix compliance in regulating EMT. When cells encounter a rigid matrix, integrins become activated, which leads to clustering and subsequent recruitment and activation of signaling proteins, including FAK. This force-induced signal promotes localization of Rac1b to the plasma membrane and formation of the NADPH oxidase complex, which results in increased generation of ROS and EMT. In cells cultured on soft matrix, integrins exist in a resting and inactive state and thereby inhibit formation of focal adhesions, the membrane localization of Rac1b, and its interaction with NADPH oxidase. Therefore, soft, compliant matrix inhibits MMP3-induced ROS production and EMT.](4097fig8){#F8}

Small GTPases act as molecular switches by cycling between GTP-bound and GDP-bound states through nucleotide exchange and hydrolysis. Rac1b contains a 19--amino acid insertion that endows it with accelerated GEF-independent nucleotide exchange and decelerated hydrolysis ([@B22]; [@B59]); as a self-activating GTPase, Rac1b essentially functions as a naturally occurring, constitutively active variant of Rac1. Here we show that the downstream signaling of Rac1b is not immutable but is determined by the physical properties of the cellular microenvironment. Given that Rac1b is expressed in a wide variety of embryonic epithelia, as well as in tumors ([@B32]), this mechanical control suggests a possible mechanism for differential signaling in development and disease. This may be particularly relevant for cancer. Because Rac1b is highly expressed in human breast cancer and particularly so in regions predicted to be stiffened ([Figure 5B](#F5){ref-type="fig"}), our data suggest that therapeutic strategies aimed at reducing the mechanical rigidity of tumors or chemically blocking the association of Rac1b with the plasma membrane may ameliorate some of its pathological effects. The latter strategy is especially intriguing because terpenoid chemotherapeutics disrupt the isoprenylation of Rac1 in rat mammary epithelium in vivo ([@B65]), and statins exhibit antitumor effects for many types of cancer ([@B67]).

Studies of mechanotransduction---the mechanisms by which individual cells sense mechanical stimuli such as substratum rigidity and transduce this information into alterations in biochemical signaling and gene expression---have revealed that mechanical cues are transmitted from focal adhesions through direct linkages to the cytoskeleton ([@B69]; [@B20]). Our data suggest that information about substratum rigidity may also be transmitted from focal adhesions through their effects on localization of key signaling molecules. Indeed, growing fibroblasts in suspension culture results in a complete loss of adhesion and blocks signaling downstream of Rac1 to its effector PAK ([@B14], [@B13]). These previous studies suggested that adhesion (or the lack thereof) acted in a binary capacity to promote membrane localization of Rac1 and thereby control anchorage-dependent cell growth ([@B11], [@B12]). Here we propose that the targeting of small GTPases to the membrane may be fine tuned by the compliance of the substratum, and thus may play a larger role in rigidity sensing and control of epithelial phenotype. Indeed, we found that the membrane localization of the Rac1 parent protein is also sensitive to matrix stiffness (Supplemental Figure S6), likely affecting signaling through a large number of downstream effectors. These data suggest a novel mode of mechanotransduction in which information transmitted through cell--ECM adhesions is conveyed to the cell through altered protein localization.

The precise mechanisms by which substratum stiffness regulates the membrane localization of Rac1 and Rac1b remain to be determined. Nonetheless, it is clear that integrin-mediated signaling plays a role, as expressing the autoclustering β1^V737N^ mutant of β1-integrin promoted Rac1b membrane localization and ROS induction when cells were cultured on soft substrata. Our findings are concordant with those of a recent study that suggested that integrin--ligand anchoring plays a role in cellular response to soft polyacrylamide substrata ([@B74]), and future investigation is needed to decouple possible effects on integrin clustering due to ligand anchoring from those due to compliance per se. Regardless, integrin clustering leads to the activation of a number of signaling pathways, including those downstream of Src-p190RhoGAP ([@B5]) and integrin-linked kinase (ILK; [@B42]), which affect cytoskeletal contractility in Rho-dependent and Rho-independent manners, respectively ([@B15]; [@B9]). Artificially inducing actomyosin-mediated contraction in cells on soft substrata promoted the translocation of Rac1b to the plasma membrane and induction of ROS (Supplemental Figure S8), suggesting a likely role for activation of the cell\'s contractile machinery in the regulation of Rac1b localization. Curiously, the membrane localization and functional activation of Rac1b appear to be independent of both Src and RhoA signaling but highly sensitive to the levels of ILK (Supplemental Figure S8). Although this is the first implication of a possible relationship with Rac1b, ILK has been shown to lead to activation of the Rac1 parent protein ([@B8]; [@B28]). Given that Rac1b is constitutively activated, it will be interesting to determine how ILK and other integrin-mediated signaling pathways function to control Rac1b localization to the plasma membrane.

Our data also suggest that the mechanical properties of the microenvironment tune the response of cells to signals that induce epithelial plasticity through EMT and a potentially fibrotic response. In effect, more-rigid microenvironments promote the induction of EMT, which may amplify fibrosis and neoplastic progression. EMT can lead to activation of myofibroblastic characteristics, associated with deposition and contraction of ECM proteins, including collagen and fibronectin, resulting in an increase in matrix density and rigidity. This ECM-associated stiffening of the tissue can in turn act to further promote pathological EMT, thus creating a mechanical self-sustaining positive-feedback loop. Our results provide insight into how to uncouple this loop---by normalizing the microenvironment, as perceived by cells, back to that of a nondiseased state---as a potential therapeutic approach to treatment of fibrosis and cancer.

MATERIALS AND METHODS
=====================

Cell culture and reagents
-------------------------

SCp2 mouse mammary epithelial cells were cultured and treated with MMP3 as described previously ([@B64]), with a 4-d time point for all experiments unless otherwise specified. Stimulation with MMP3 was achieved by treating cells with medium that had been conditioned by cells stably expressing tetracycline-regulated, autoactivated MMP3; MMP3 expression was induced by growth in the absence of tetracycline. Conditioned medium from cells repressed by treatment with tetracycline was used for controls. For gene repression, a 4 mg/ml stock solution of tetracycline (Sigma-Aldrich, St. Louis, MO) in 100% ethanol was diluted 1:800 into culture medium and changed daily. For other experiments, mammary epithelial cells were treated with 25 μM H~2~O~2~ for 4 d. The following reagents were used at the concentrations indicated: NADPH oxidase inhibitor DPI, 0.1 μM (Sigma-Aldrich); mevinolin, 0.5 μM (Sigma-Aldrich); TGFβ type I receptor (Alk-5) kinase inhibitor \[3-(pyridine-2-yl)-4-(4-quinonyl)\]-1H-pyrazole, 0.36 μM (Calbiochem, La Jolla, CA); calyculin A, 1 μM (Calbiochem); Src inhibitor PP2 (Tocris Bioscience, Ellisville, MO); and Rho inhibitor I (Cytoskeleton, Denver, CO).

Synthetic substrata
-------------------

Polyacrylamide gels with a fixed acrylamide monomer concentration of 5% and bis-acrylamide cross-linker concentrations ranging from 0.01 to 0.35% were prepared using a protocol adapted from [@B61]). Briefly, glass coverslips were treated with 0.1 N NaOH for 5 min, followed by rinsing in Millipore water (Millipore, Billerica, MA) and drying. Coverslips were then soaked in a 2% (vol/vol) solution of aminopropyltrimethoxysilane (Sigma-Aldrich) in acetone for 10 min, rinsed extensively with acetone, and air dried. Next the coverslips were incubated in a solution of 0.5% (vol/vol) glutaraldehyde (Sigma-Aldrich) in phosphate-buffered saline (PBS) for 30 min, followed by extensive rinsing with Millipore water. Acrylamide was mixed with bis-acrylamide, ammonium persulfate (1/200), and *N*,*N*,*N*′,*N*′-tetramethylethylenediamine (1/2000, TEMED; Bio-Rad, Hercules, CA), and 36 μl was placed onto the activated coverslip surface. The acrylamide solution was then covered by a 32-mm-diameter dichlorodimethylsilane-treated (Sigma-Aldrich) coverslip and allowed to polymerize for 30 min. The top coverslip was carefully removed, and the gel was rinsed with PBS.

Fibronectin is normally present within the mouse mammary gland ([@B23]) and by itself does not promote EMT in mammary epithelial cells ([@B70]). Accordingly, fibronectin was cross-linked to the gel surfaces through the use of sulfosuccinimidyl-6-(4′-azido-2′-nitrophenyl-amino)-hexanoate (sulfo-SANPAH; Pierce, Rockford, IL) chemistry. Polyacrylamide gels were rinsed in a solution of 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 8.5. The gel surfaces were then treated with a 2 mM solution of sulfo-SANPAH and exposed to a germicidal ultraviolet lamp for 10 min. Gels were rinsed once with 50 mM HEPES, pH 8.5, and then the sulfo-SANPAH treatment was repeated. Gels were rinsed twice with HEPES and then incubated with 0.2 mg/ml human fibronectin (BD Biosciences, San Diego, CA) overnight at 4°C. Before plating of cells, gels were rinsed extensively with PBS, followed by incubation in culture media at 37ºC for 1 h.

Characterization of substrata by enzyme-linked immunosorbent assay
------------------------------------------------------------------

The amount of fibronectin conjugated to the surface of the polyacrylamide gels was measured using an enzyme-linked immunosorbent assay. Fibronectin-conjugated gels were washed extensively in PBS to remove excess fibronectin and then incubated with blocking buffer (1% bovine serum albumin in PBS). The gels were then incubated successively with biotinylated anti-fibronectin, streptavidin-conjugated β-galatosidase (Invitrogen, Carlsbad, CA), and *p*-nitrophenyl-β-[d]{.smallcaps}-galactopyranoside (Sigma-Aldrich). The reaction was stopped with 0.5 M sodium carbonate. The optical density at 405 nm was measured in a plate reader (Promega, Madison, WI) and compared with that for untreated gels. This analysis revealed that substrata had comparable densities of surface-associated ECM protein (Supplemental Figure S1).

Characterization of substrata by rheometry
------------------------------------------

The viscoelastic properties of the polyacrylamide gels were measured with an Anton Paar MCR 501 rheometer (Anton Paar, Ashland, VA), using 25-mm parallel plates at a gap height of 0.8--1.3 mm. Bulk gels (∼1 mm thick) were prepared by polymerizing acrylamide solution between two dichlorodimethylsilane-treated coverslips. Measurements were performed on gels hydrated with culture media. A Peltier plate was used to maintain the temperature at 37°C, and a humidity chamber was used to prevent dehydration of the sample. All measurements were performed in the linear viscoelastic regime. Values of Young\'s modulus (*E*) of the polyacrylamide gels were computed from measured shear modulus, *G*, using the equation *E* = 2*G*(1 + ν), where ν is the Poisson ratio (ν = 0.48 for polyacrylamide; [@B7]).

Transfections and adenoviral transductions
------------------------------------------

Rac1b was cloned from cDNA isolated from SCp2 mouse mammary epithelial cells and fused with YFP using the pEYFP-C1 plasmid (Clontech, Mountain View, CA) as previously described ([@B64]). SAAX and myristoylation mutants were generated using the QuikChange II XL site-directed mutagenesis kit (Stratagene, Santa Clara, CA). The autoclustering β1-integrin mutant (β1^V737N^) was generated using the QuikChange Lightning site-directed mutagenesis kit (Stratagene). Mutations were verified by sequencing. Cells were plated onto polyacrylamide substrata 24 h after transfection with plasmids using FuGENE HD (Roche, Indianapolis, IN). Recombinant adenovirus encoding human Snail (Ad-Snail) was a gift from Paul Wade (National Institute of Environmental Health Sciences, Research Triangle Park, NC; [@B33]). Custom recombinant adenoviruses encoding YFP-tagged mouse Rac1b (Ad-Rac1b), its mutants (Ad-Rac1b-myr and Ad-Rac1b-SAAX), and control adenovirus encoding GFP (Ad-GFP) were obtained from Vector BioLabs (Burlingame, CA). High-titer preparations of recombinant adenoviruses were generated using the AdEasy virus purification kit (Stratagene). Cells were transduced at a multiplicity of infection resulting in \>99% transduction efficiency.

For knockdown of β1-integrin, gene silencing was accomplished using Mission shRNA as previously described ([@B59]); five constructs targeting mouse β1-integrin were evaluated, and significant knockdown was observed using clone NM_010578,1-111s1c1.

Quantitative real-time PCR
--------------------------

Total RNA was isolated using either a Qiagen RNeasy Mini Kit or TRIzol reagent (Invitrogen), followed by cDNA synthesis using a Super Script First-Strand Synthesis Kit (Invitrogen). Transcript levels were measured by quantitative real-time PCR using a Bio-Rad Mini-Opticon instrument and SYBR Green chemistry. Amplification was followed by melting curve analysis to verify the presence of a single PCR product. Primers for keratin-14, E-cadherin, αSMA, Rac1b, Snail, vimentin, and 18S rRNA (Supplemental Table S1) were designed using Beacon Designer software (Bio-Rad) and determined to be specific by BLAST and dissociation curve analysis. The expression level of each mRNA was normalized to that of 18S in the same sample.

Coimmunoprecipitation
---------------------

SCp2 or MCF10A cells expressing GFP or YFP-Rac1b were cultured on soft (130 Pa) or stiff (4020 Pa) polyacrylamide substratum. Whole-cell lysates were prepared using lysis buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 0.1% NP-40, 1 mM dithiothreitol, 1 mM Na~3~VO~4~, 10 mM NaF, and protease inhibitor cocktail) and immunoprecipitated with anti-GFP (Sigma-Aldrich) or anti-Rac1b ([@B64]) antibody. The whole-cell lysates and immunoprecipitation products were subject to immunoblotting to detect p67^phox^ (Millipore), p47^phox^ (Millipore), Rac1b (Millipore), and GFP.

Immunoblotting
--------------

Samples were lysed using RIPA buffer, mixed with Laemmli sample buffer, boiled at 95°C for 5 min, resolved by SDS--PAGE, and transferred to nitrocellulose. Membranes were blocked in 5% milk and incubated overnight at 4°C in blocking buffer containing antibodies specific for Rac1b ([@B64]), Rac1 (Cytoskeleton), Snail (Cell Signaling, Beverly, MA), E-cadherin (Cell Signaling), or actin (Cell Signaling). The signals were visualized using the ECL Plus Western Blotting Detection System (GE Healthcare, Piscataway, NJ).

Immunofluorescence
------------------

For staining of keratins, samples were fixed with an ice-cold solution of 1:1 methanol/acetone at −20ºC for 10 min, followed by rinsing with PBS. After blocking for 1 h with 10% goat serum (Sigma-Aldrich) and 0.5% Tween (Sigma-Aldrich), the samples were then incubated for 1 h with rabbit anti-pan keratin (Dako, Carpinteria, CA). Samples were then rinsed and incubated with Alexa 594 goat anti--rabbit immunoglobulin G (IgG; Invitrogen). Nuclei were counterstained with Hoechst 33342 (Invitrogen). Levels of cellular ROS were assessed by staining with 5-(and-6)carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H~2~DCFDA; Invitrogen) or CellROX Deep Red reagent (Invitrogen). Samples were incubated in the dark with 50 μM carboxy-H~2~DCFDA or 5 μM CellROX in serum- and phenol red--free media for 30 min. For staining of pFAK, samples were fixed with 4% paraformaldehyde in PBS for 15 min, followed by rinsing with PBS and permeabilization with 0.1% Triton X-100 for 15 min. After blocking for 1 h with 10% goat serum (Sigma-Aldrich), the samples were then incubated at 4°C overnight with rabbit anti-FAK (pY^397^; Invitrogen). Samples were then rinsed and incubated with Alexa 594 goat anti--rabbit IgG for 1 h.

Microscopy and analysis
-----------------------

Samples were imaged using a 10× (numerical aperture \[NA\] 0.30), 20× (NA 0.45), or 40× (NA 0.60) air objective on a Nikon Eclipse Ti-U inverted fluorescence microscope (Nikon, Melville, NY) equipped with a Hamamatsu ORCA charge-coupled device camera (Hamamatsu, Hamamatsu, Japan). Confocal images were collected using a Hamamatsu ER camera coupled to a spinning disk confocal microscope (Bio-Rad). Image analysis was performed using ImageJ (National Institutes of Health, Bethesda, MD) and Photoshop (Adobe, San Jose, CA) software. Focal adhesions were quantified using a modification of the Water algorithm ([@B56]) as follows. Original images of immunostained cells were filtered to subtract background fluorescence and segmented with a threshold of 0.45 μm^2^ to quantify the number of focal adhesions per cell. Analysis was performed on at least 130 cells over at least three independent experiments. Statistical analysis was performed using the unpaired Student\'s *t* test.

Immunohistochemical analysis
----------------------------

Nonmalignant breast tissue (cancer-free prophylactic mastectomy) and breast cancer biopsies were derived from waste surgical material from deidentified patients and were Formalin fixed and paraffin embedded. Sections from four nonmalignant and four breast cancer samples were evaluated. For immunohistochemistry, tissue sections were deparaffinized by placing them into three changes of xylene and rehydrated in a graded ethanol series. The rehydrated tissue samples were rinsed in water, and sections were subjected to heat antigen retrieval as described by the manufacturer (Dako). Slices were incubated with the appropriate primary antibody (Rac1b, Millipore; Collagen I, Abcam, Cambridge, MA) for 30 min at room temperature. Sections were then rinsed with Tris-buffered saline/Triton X-100 (TBST) wash buffer, and secondary incubation was with Dako DUAL+ horseradish peroxidase for 15 min. Tissue slices were rinsed with TBST wash buffer and then incubated in 3,3′-diaminobenzidine (DAB+; Dako) and counterstained with modified Schmidt\'s hematoxylin.
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